Wave Life Sciences to Present at Upcoming Investor Conferences
Wave Life Sciences (Nasdaq: WVE), a clinical-stage genetic medicines company, announced that Paul Bolno, MD, CEO, will participate in two investor conferences in May 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Wave Life Sciences (Nasdaq: WVE), a clinical-stage genetic medicines company, announced that Paul Bolno, MD, CEO, will participate in two investor conferences in May 2022. The first is at the RBC Capital Markets 2022 Global Healthcare Conference on May 17, 2022, from 2:05 p.m. to 2:30 p.m. ET in New York. The second is at the H.C. Wainwright Global Investment Conference on May 24, 2022, from 3:30 p.m. to 4:00 p.m. ET in Miami. Live webcasts will be available on their Investor Relations page.
Details
News Market Reaction – WVE
The recorded move for WVE in the trading session of this news was +7.28%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in two upcoming investors conferences in May.
RBC Capital Markets 2022 Global Healthcare Conference (New York, NY)
Date: Tuesday, May 17, 2022
Analyst-led fireside chat presentation time: 2:05 p.m. – 2:30 p.m. ET
H.C. Wainwright Global Investment Conference (Miami, FL)
Date: Tuesday, May 24, 2022
Analyst-led fireside chat presentation time: 3:30 p.m. – 4:00 p.m. ET
Live webcasts of these presentations will be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. Replays of these presentations will be archived and available on the site for a limited time following the event.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.
Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com
Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.